Mar 21, 2025
Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery
Oct 28, 2024
Lupin to focus on the development of inhalers with near-zero global warming potential propellants
Jul 15, 2024
Lupin Divests U.S. Commercial Women's Health Specialty Business to Evofem, including SOLOSEC
Aug 14, 2020
Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis
Jun 11, 2020
Lupin Pharmaceuticals and PlushCare Expand Access to Bacterial Vaginosis (BV) Treatment to Help Meet Patient Needs During COVID-19 Pandemic
Jun 09, 2020
Lupin Signs Marketing Agreement With Ceek for Women's Health Products to Improve OB/GYN and Patient Exam Experience
Jun 09, 2020
Ceek and Lupin Sign a Marketing Agreement to Improve OB/GYN and Patient Exam Experience with the Nella® Products
Jun 04, 2020
Mylan and Lupin Receive European Marketing Authorization for Nepexto®, Biosimilar Etanercept
May 04, 2020
Lupin Announces Positive Topline Results From its Phase 3 Study of Single-Dose Solosec® (secnidazole) for the Treatment of Trichomoniasis
Apr 22, 2020
Lupin Announces SOLOSEC® (secnidazole) Achievement of Preferred Status on Express Scripts National Preferred Formulary, One of the Largest Commercial Formularies in the U.S.
Apr 06, 2020
The global anti-rheumatics market is anticipated to record a CAGR of 2.32% during the projected period of 2020-2028
Mar 27, 2020
Mylan and Lupin Announce Positive CHMP Opinion for Nepexto®, Biosimilar Etanercept
Sep 12, 2019
Global Neurology Market Research Overview 2019: Competitive Environment, Regulations, Epidemiology, M&As, Pipeline Drugs
Jun 06, 2019
Visiongain Report Provides Critical Market-led Data on the $36bn Dermatological Drugs Market
Dec 06, 2018
ZAXINE® (rifaximin) - Now Indicated in Canada for Patients with Irritable Bowel Syndrome with Diarrhea (IBS-D)1,2
Dec 04, 2018
Global Opioids Drug Market Forecast 2019-2027
Sep 06, 2018
LEUKOCARE and Xellia Pharmaceuticals Partner to Discover Innovative Formulations for the Development of Value-added Anti-infective Therapies
Aug 30, 2018
Global Advanced Drug Delivery Systems Market, 2024: Pulmonary Applications to Lead Advanced Drug Delivery Systems Market to Touch $277 Billion
Jun 28, 2018
Lupin and Mylan Partner to Commercialize Enbrel® (Etanercept) Biosimilar
Apr 30, 2018
$20 Million Class Action Settlement has been Reached for Purchasers of Solodyn®